Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

Item
http://www.wikidata.org/entity/Q49102895
Comparison of aspects of smoking among the four histological types of lung cancerA Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study.Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer.Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limConsolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.Surgery in limited-disease small-cell lung cancer.Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
P2860

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

Item
http://www.wikidata.org/entity/Q49102895
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Patients with limited-stage sm ...... doxorubicin, and vincristine.
@en
Patients with limited-stage sm ...... doxorubicin, and vincristine.
@nl
type
label
Patients with limited-stage sm ...... doxorubicin, and vincristine.
@en
Patients with limited-stage sm ...... doxorubicin, and vincristine.
@nl
prefLabel
Patients with limited-stage sm ...... doxorubicin, and vincristine.
@en
Patients with limited-stage sm ...... doxorubicin, and vincristine.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Patients with limited-stage sm ...... doxorubicin, and vincristine.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921